HCIT & Life Sciences
HCIT & Life Sciences
Transactions
"We engaged AGC because of its track record, deep market knowledge, and relationships. That perspective proved invaluable to the Board and a mission-oriented shareholder group in forming a consensus to divest Exostar from joint venture to private equity ownership. I can't speak more highly of the tenacity and professionalism that Maria, Russ and the AGC team brought to the table every day to advance our strategic interests. We are excited at the prospect of moving forward under Thoma Bravo's stewardship, and the deal absolutely would not have happened without AGC. AGC has earned my highest recommendation."
AGC Partners acted as sole financial advisor to Exostar in June, 2020
Related Insights
© In the U.S., America’s Growth Capital, LLC dba AGC Partners, member FINRA/SIPC. In Europe, America’s Growth Capital Europe, LLP (Appointed Representative Alternatives St. James, LLP which is authorized and regulated by the Financial Conduct Authority). America’s Growth Capital Europe, LLP is a Limited Liability Partnership incorporated in England and Wales (OC368580). Its registered address is 6th Floor, 9 Appold Street, London EC2A 2AP. The testimonials contained herein may not be representative of the experience of other customers or clients. Testimonials are no guarantee of future performance or success. Deals marked with an “*” are non-AGC deals.